Showing results (201-210 of 270) with videos related to

Sort By:
Pageof 27
Gut|November 21, 1998
Oncological implications of RET gene mutations in Hirschsprung's diseaseR H Sijmons, R M Hofstra, F A Wijburg, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 22, 2013
Plasma proprotein convertase subtilisin kexin type 9 levels are related to markers of cholesterol synthesis in familial combined hyperlipidemiaM C G J Brouwers, R J Konrad, T M van Himbergen, et al.
Metabolism: Clinical and Experimental|September 22, 2007
Fatty liver--based identification of two distinct hypertriglyceridemic subgroups in familial combined hyperlipidemiaMartijn C G J Brouwers, Marleen M J van Greevenbroek, Monique A L Bilderbeek-Beckers, et al.
BMJ Open Diabetes Research & Care|March 21, 2020
Incidence of type 2 diabetes in familial combined hyperlipidemiaMartijn C G J Brouwers, Jacqueline de Graaf, Nynke Simons, et al.
Atherosclerosis|November 19, 2018
Incidence of cardiovascular disease in familial combined hyperlipidemia: A 15-year follow-up studyJim Luijten, Marleen M J van Greevenbroek, Nicolaas C Schaper, et al.
Thrombosis and Haemostasis|December 24, 2003
Potential interaction between acenocoumarol and diclofenac, naproxen and ibuprofen and role of CYP2C9 genotypeKaren N van Dijk, Arian W Plat, Alieke A C van Dijk, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 31, 2004
Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotypeA M Georgieva, M M J van Greevenbroek, R M Krauss, et al.
Clinical Pharmacokinetics|January 20, 2017
Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment OptionsRoelof W F van Leeuwen, Frank G A Jansman, Nicole G Hunfeld, et al.
Journal of Lipid Research|September 15, 2006
Heritability and genetic loci of fatty liver in familial combined hyperlipidemiaMartijn C G J Brouwers, Rita M Cantor, Naoko Kono, et al.
Pageof 27